SecBot SecBot
S-3 ·Filed Nov 16, 2026
AZ

AZR

Azora Therapeutics, Inc. (DE)
BEARISH
Impact 6/10
Processed11h 36m ago SEC0001213900-26-121039
Shelf registration (potential dilution)

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
S-3 Filing (Primary)0001213900-26-121039
Document: ea031229401ex4-3.htm0001213900-26-121039
Document: ea031229401ex1-2.htm0001213900-26-121039

Track record

5 reports on AZR

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 2026today S-3 Bearish 6/10 Viewing Entry $3.81 Now $3.66 +3.81% settles Nov 24
  2. Nov 12, 20265d ago 8-K Neutral 4/10 Entry $4.09 Now $3.66 −10.39% settles Nov 20
  3. Nov 10, 20267d ago 3 Neutral 2/10 Entry $3.76 to $3.67 Now $3.66 −2.53% ▼ −2.53% −0.20% vs SPY
  4. Nov 9, 20268d ago 8-K Neutral 4/10 Entry $3.75 to $3.81 Now $3.66 −2.27% ▲ +1.60% +3.29% vs SPY
  5. Nov 3, 202614d ago SC 13G/A Bearish 4/10 Entry $4.15 to $3.76 Now $3.66 +11.69% ▲ +9.40% +8.81% vs SPY
Showing 5 of 5

US Market Status

Market Closed · Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 17, 2026

Fresh AZR Intelligence

Analysis is for subscribers only.

Subscribe for Full Access